Methods of treating inflammatory diseases with combination of TL1A inhibitors and IL23 inhibitors
Described herein are methods of treating inflammatory diseases or conditions such as inflammatory bowel diseases including Crohn's disease and ulcerative colitis, the methods comprising administering a TL1A inhibitor and an IL23 inhibitor contemporaneously for the duration of treatment or conte...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | LLEWELLYN, HEATHER MUNOZ, ERNESTO J BARNETT, BURTON |
description | Described herein are methods of treating inflammatory diseases or conditions such as inflammatory bowel diseases including Crohn's disease and ulcerative colitis, the methods comprising administering a TL1A inhibitor and an IL23 inhibitor contemporaneously for the duration of treatment or contemporaneously during an induction phase of treatment followed by maintenance of response with the TL1A inhibitor alone or IL23 inhibitor alone. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW202346344A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW202346344A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW202346344A3</originalsourceid><addsrcrecordid>eNqNy7EKwjAQxvEsDqK-w_kAgibBvYiiULeAY7m2l_agSUovIL69FRwcnT748_uWCu-U-9QKJA95IswcO-DoBwwBc5pe0LIQCgk8OffQpFBznFmKn4srD8XMe655xgIYW7iV2vy0tVp4HIQ2312p7eXsTtcdjakiGbGhSLlyD73Xxh6NtYX5x7wB2fE9OA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Methods of treating inflammatory diseases with combination of TL1A inhibitors and IL23 inhibitors</title><source>esp@cenet</source><creator>LLEWELLYN, HEATHER ; MUNOZ, ERNESTO J ; BARNETT, BURTON</creator><creatorcontrib>LLEWELLYN, HEATHER ; MUNOZ, ERNESTO J ; BARNETT, BURTON</creatorcontrib><description>Described herein are methods of treating inflammatory diseases or conditions such as inflammatory bowel diseases including Crohn's disease and ulcerative colitis, the methods comprising administering a TL1A inhibitor and an IL23 inhibitor contemporaneously for the duration of treatment or contemporaneously during an induction phase of treatment followed by maintenance of response with the TL1A inhibitor alone or IL23 inhibitor alone.</description><language>chi ; eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231201&DB=EPODOC&CC=TW&NR=202346344A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231201&DB=EPODOC&CC=TW&NR=202346344A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LLEWELLYN, HEATHER</creatorcontrib><creatorcontrib>MUNOZ, ERNESTO J</creatorcontrib><creatorcontrib>BARNETT, BURTON</creatorcontrib><title>Methods of treating inflammatory diseases with combination of TL1A inhibitors and IL23 inhibitors</title><description>Described herein are methods of treating inflammatory diseases or conditions such as inflammatory bowel diseases including Crohn's disease and ulcerative colitis, the methods comprising administering a TL1A inhibitor and an IL23 inhibitor contemporaneously for the duration of treatment or contemporaneously during an induction phase of treatment followed by maintenance of response with the TL1A inhibitor alone or IL23 inhibitor alone.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNy7EKwjAQxvEsDqK-w_kAgibBvYiiULeAY7m2l_agSUovIL69FRwcnT748_uWCu-U-9QKJA95IswcO-DoBwwBc5pe0LIQCgk8OffQpFBznFmKn4srD8XMe655xgIYW7iV2vy0tVp4HIQ2312p7eXsTtcdjakiGbGhSLlyD73Xxh6NtYX5x7wB2fE9OA</recordid><startdate>20231201</startdate><enddate>20231201</enddate><creator>LLEWELLYN, HEATHER</creator><creator>MUNOZ, ERNESTO J</creator><creator>BARNETT, BURTON</creator><scope>EVB</scope></search><sort><creationdate>20231201</creationdate><title>Methods of treating inflammatory diseases with combination of TL1A inhibitors and IL23 inhibitors</title><author>LLEWELLYN, HEATHER ; MUNOZ, ERNESTO J ; BARNETT, BURTON</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW202346344A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LLEWELLYN, HEATHER</creatorcontrib><creatorcontrib>MUNOZ, ERNESTO J</creatorcontrib><creatorcontrib>BARNETT, BURTON</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LLEWELLYN, HEATHER</au><au>MUNOZ, ERNESTO J</au><au>BARNETT, BURTON</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Methods of treating inflammatory diseases with combination of TL1A inhibitors and IL23 inhibitors</title><date>2023-12-01</date><risdate>2023</risdate><abstract>Described herein are methods of treating inflammatory diseases or conditions such as inflammatory bowel diseases including Crohn's disease and ulcerative colitis, the methods comprising administering a TL1A inhibitor and an IL23 inhibitor contemporaneously for the duration of treatment or contemporaneously during an induction phase of treatment followed by maintenance of response with the TL1A inhibitor alone or IL23 inhibitor alone.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | chi ; eng |
recordid | cdi_epo_espacenet_TW202346344A |
source | esp@cenet |
subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Methods of treating inflammatory diseases with combination of TL1A inhibitors and IL23 inhibitors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T17%3A47%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LLEWELLYN,%20HEATHER&rft.date=2023-12-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW202346344A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |